Regulations.gov document
Draft Guidance for Industry on an Amendment Involving Donor Deferral for Transfusion in…
Notice · FDA-1997-D-0008 · posted Aug 14, 2006
Key facts
| Document ID | FDA-1997-D-0008-0003 |
|---|---|
| Title | Draft Guidance for Industry on an Amendment Involving Donor Deferral for Transfusion in France Since 1980 to "Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products"; Availability |
| Document type | Notice |
| Subtype | Notice of Data Availability |
| Agency | FDA |
| Docket | FDA-1997-D-0008 |
| Posted | Aug 14, 2006 |
| Federal Register citation | 71 FR 46484 |
| FR document number | E6-13234 |
| Comment period opens | Aug 11, 2006 |
| Comments due | Oct 14, 2006 |
| Effective date | Aug 1, 2006 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: